echoloc
Get started
echoloc/ Companies/ Deep Origin

Deep Origin Tech Stack

AI-driven drug discovery platform with computational biology simulation

Biotechnology Research South San Francisco, California 51–200 employees Founded 2022 Privately Held
deeporigin.com LinkedIn

Deep Origin builds computational tools for drug discovery, combining physics-based molecular simulation (GROMACS, OpenMM) with machine learning (scikit-learn, RDKit) on managed cloud infrastructure (AWS, Kubernetes, Slurm). Heavy hiring in research (7 roles) and senior/VP leadership (9 roles combined) reflects a company scaling AI-driven workflows into biotech R&D pipelines, not just infrastructure—the pain-point list centers on reducing failure rates, accelerating timelines, and eliminating animal testing through better in-silico prediction.

Tech Stack 37 technologies

Core StackAWS Kubernetes Terraform Ansible Prometheus Grafana OpenTelemetry Elasticsearch AWS RDS scikit-learn Python Jira NumPy Pandas Node.js TypeScript JavaScript PostgreSQL AWS EKS Slurm IAM GROMACS RDKit PyMOL SLURM Microsoft Project SciPy OpenMM C/C++ Julia+7 more

What Deep Origin Is Building

◆Challenges

  • Expanding predictive toxicology
  • Reducing failure rates
  • Accelerating drug development
  • Eliminating animal testing
  • Scaling whole-human modeling capabilities
  • Scaling ai-driven platform
  • Supporting r&d compute clusters
  • Reducing drug discovery cost
  • Scaling platform for biotech
  • Integrating ai-driven approaches

▲Active Projects

  • Lead optimization
  • Ai-driven computational integration into drug discovery workflows
  • Arpa-h initiative
  • Small-molecule drug discovery program
  • Target identification
  • Hit discovery
  • Cloud infrastructure across aws and third-party hosting
  • Bare-metal compute cluster operations
  • Slurm job scheduling
  • Ai-driven drug discovery platform

Hiring Activity

Accelerating10 roles · 10 in 30d

Department

Research
7
Engineering
2
Product
2

Seniority

Senior
5
VP
4
Principal
2
Company intelligence

Find more companies like Deep Origin by tech stack, pain points and active projects

Get started free

About Deep Origin

Deep Origin develops computational platforms for drug discovery, targeting biotech researchers and pharmaceutical R&D teams. The product suite spans molecular modeling (lead optimization, hit discovery, target identification), AI integration into discovery workflows, and managed cloud compute infrastructure (bare-metal clusters via Slurm, AWS EKS). Founded in 2022 and headquartered in South San Francisco, the company operates 51–200 employees and is hiring aggressively across research, engineering, and product roles, with presence in the US, Armenia, and Portugal. Their stated focus is reducing drug development cost and failure rates through computational biology and AI.

HeadquartersSouth San Francisco, California
Company Size51–200 employees
Founded2022
Hiring MarketsUnited States, Armenia, Portugal

Frequently Asked Questions

What is Deep Origin's tech stack?

Deep Origin uses AWS infrastructure (EKS, RDS, IAM), Kubernetes, Terraform, Slurm for job scheduling, and molecular simulation tools (GROMACS, OpenMM, RDKit, PyMOL). ML/data stack includes scikit-learn, NumPy, SciPy, Pandas, and Elasticsearch. Backend uses Python, C/C++, Node.js, TypeScript, and Julia.

Where is Deep Origin headquartered?

Deep Origin is headquartered in South San Francisco, California. The company hires in the United States, Armenia, and Portugal.

How this profile is built

Deep Origin's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.